Finding 607276 (2022-002)

Material Weakness
Requirement
I
Questioned Costs
-
Year
2022
Accepted
2023-06-12

AI Summary

  • Core Issue: The Organization lacks a written procurement policy as required by federal regulations.
  • Impacted Requirements: Noncompliance with Title 2, Subtitle A, Chapter 2 Part 200, Subpart D, section 200.318 of the Code of Federal Regulations.
  • Recommended Follow-Up: Develop and implement a procurement policy that aligns with federal requirements.

Finding Text

Federal Agency: Department of Health and Human Services Federal Program: Research and Development Cluster Assistance Listing Number: 93.847 & 93.867 Federal Award Identification Number and Year: Various Award Period: January 1, 2022, through December 31, 2022 Type of Finding: Other Matters Finding related to Compliance within Uniform Guidance and Material Weakness in Internal Control Over Compliance Criteria or specific requirement: Title 2, Subtitle A, Chapter 2 Part 200, Subpart D, section 200.318 of the Code of Federal Regulations requires organizations to have a written procurement policy that includes certain requirements as it relates to procuring goods and services using federal dollars. Condition: Noncompliance with procurement requirements under Uniform Guidance. Questioned costs: None Context: During our testing, it was noted that the Organization does not have a written procurement policy in place that covers the requirements noted in Section 200.318 of the Code of Federal Regulations. Cause: Prior to 2022, the Organization was unaware of this federal requirement. Effect: Not following proper procedure is in direct violation of Section 200.318 of the Code of Federal Regulations. Repeat Finding: No. Recommendation: We recommend that the Organization develop a written procurement policy that meets the requirements noted in Section 200.318 of the Code of Federal Regulations. Views of responsible officials and Planned Corrective Actions: There is no disagreement with the audit finding. See Corrective Action Plan prepared by the Organization.

Categories

Procurement, Suspension & Debarment Material Weakness Internal Control / Segregation of Duties

Other Findings in this Audit

  • 30818 2022-002
    Material Weakness
  • 30819 2022-003
    Material Weakness
  • 30820 2022-002
    Material Weakness
  • 30821 2022-003
    Material Weakness
  • 30822 2022-002
    Material Weakness
  • 30823 2022-003
    Material Weakness
  • 30824 2022-002
    Material Weakness
  • 30825 2022-003
    Material Weakness
  • 30826 2022-002
    Material Weakness
  • 30827 2022-003
    Material Weakness
  • 30828 2022-002
    Material Weakness
  • 30829 2022-003
    Material Weakness
  • 30830 2022-002
    Material Weakness
  • 30831 2022-003
    Material Weakness
  • 30832 2022-002
    Material Weakness
  • 30833 2022-003
    Material Weakness
  • 30834 2022-002
    Material Weakness
  • 30835 2022-003
    Material Weakness
  • 607260 2022-002
    Material Weakness
  • 607261 2022-003
    Material Weakness
  • 607262 2022-002
    Material Weakness
  • 607263 2022-003
    Material Weakness
  • 607264 2022-002
    Material Weakness
  • 607265 2022-003
    Material Weakness
  • 607266 2022-002
    Material Weakness
  • 607267 2022-003
    Material Weakness
  • 607268 2022-002
    Material Weakness
  • 607269 2022-003
    Material Weakness
  • 607270 2022-002
    Material Weakness
  • 607271 2022-003
    Material Weakness
  • 607272 2022-002
    Material Weakness
  • 607273 2022-003
    Material Weakness
  • 607274 2022-002
    Material Weakness
  • 607275 2022-003
    Material Weakness
  • 607277 2022-003
    Material Weakness

Programs in Audit

ALN Program Name Expenditures
93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research $805,072
93.867 Vision Research $208,297